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Glycosylation of cyclooxygenase-2 (COX-2) 
influences the migratory and invasive potential of 
cells
Fahad Algaly, Julia Hand and Mary B. Sevigny 
Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA 94901
ABSTRACT
Prostaglandins are bioactive lipids involved in many
physiological functions such as maintenance of the
cardiovascular, immune, renal, and central nervous
systems. They also play a role in certain diseases like
arthritis, cancer, and Alzheimer’s. Cyclooxygenase-2 (COX-
2) is the enzyme that catalyzes the initial rate-limiting step
in the pathway that converts arachidonic acid to
prostaglandins. COX-2 exists as two glycoforms with the
molecular weights of 72 and 74 kDa, the latter resulting from
the addition of a high mannose chain to the Asn580 residue
~50% of the time. The over-expression of COX-2 is believed
to be linked to cancer progression and specifically appears
to promote the metastatic phenotype. The objective of this
study is to determine the effect of the variable glycosylation
of COX-2 at Asn580 on the migratory and invasive potential
of cells. COS-1 cells and the breast cancer cell line MCF7
were first transfected with either the wild type or Asn580-
mutant human COX-2 gene. Boyden chambers were used to
determine the ability of transfected cells to migrate through
the membrane, approximately 5x104 cells were plated onto
the chambers, and cells were incubated for 16-18 h. Cells
were then fixed, stained, visualized and counted. In a
previous study, our lab showed that COS-1 cells transfected
with the Asn580-mutant COX-2 gene migrated faster through
the membrane. In this current study, COS-1 cells transfected
with the Asn580-mutant COX-2 gene also had a greater
invasive potential; however, MCF7 cells transfected with the
wild-type human COX-2 gene migrated faster and also had a
greater tendency to invade. The results indicate that the
ability of this additional or the lack of glycosylation of COX-
2 at Asn580 to either enhance or inhibit the migratory and
invasive potential of cells depends greatly on cell type. To
confirm this, future studies will be carried out to determine
the effect of COX-2 glycosylation on the invasive and the
migratory potential of PC-3 and T-47D cancer cell lines.
METHODS
Transfection of COS-1 and MCF-7 cells with the COX-2
gene
The transfection of cells with either the wild-type human COX-2
gene or the Asn580-mutant human COX-2 gene was carried out in
5% FBS/DMEM using TransIt-LT1 transfection reagent. Control
cells were transfected with an empty pcDNA3.1 plasmid from
Invitrogen. Transfection efficiency was confirmed by co-transfection
with pEGFP-1 followed by fluorescent microscopy
detection. Expression of the COX-2 glycoforms was verified via
Western blots.
Analysis of cell migration and invasion
Transfected cells at a density of 5 x 104 cells per well were plated
onto Boyden chambers with 8 µm pore size or onto modified
Boyden chambers with an extra layer of matrigel to test cells’
migratory and invasive potential, respectively. Cells were then
incubated at 37 C. After 12-18 hours of incubation, cells were fixed
in 10% phosphate buffered formalin. Crystal violet was used to
stain cells, and then the chambers were placed in distilled H2O to
rinse off any excess crystal violet. Cotton swabs were used to
gently clean the insides of the Boyden chambers. After drying, the
membranes were viewed under a light microscope using the
computer program MOTIC to view and capture the images. The
pictures were used to count how many cells migrated or invaded
across the membranes.
Expression level of prostaglandin E2 (PGE2) receptors
Total RNA was isolated from the transfected MCF-7 cells using TRI
Reagent following the manufacturer’s protocol. After isolation, first
strand cDNA was made, and PCR was carried out to determine the
expression levels of the four PGE2 receptors– EP1, EP2, EP3, and
EP4. ß-actin gene was used as house-keeping gene for
normalization. CONCLUSIONS
Our lab has previously shown that this additional glycosylation
plays a role in the turnover of the COX-2 enzyme and
negatively affects the efficacy of various COX-2 inhibitors.
Since other researchers have shown that overexpression of
COX-2 in cells leads to a more enhanced metastatic
phenotype, our lab is interested in determining if the
glycosylation of COX-2 affects this as well. Therefore, the
purpose of this study is to find out if the metastatic
potential of COX-2-expressing cells depends upon which
glycoform(s) is(are) expressed.
Western blot data showing expression of the COX-2 glycoforms. C =
control, COS-1 cells transfected with empty plasmid; WT = COS-1 cells
transfected with the wild-type COX-2 gene; MUT = COS-1 cells
transfected with the mutant gene. Cells transfected with the wild-type gene
expressed the 72 and 74 kDa glycoforms whereas cells transfected with
the Asn580-mutant gene expressed the 72 and a “new” 70 kDa glycoform.
Figure 3
INTRODUCTION
COX-2 is an enzyme expressed in most cells. It’s the
enzyme involved in the formation of prostaglandins from
arachidonic acid. Prostaglandins (PGs) are a group of lipids
that impact our body both positively and negatively. They
improve circulation and nerve formation, increase T-cell
formation, regulate blood pressure, and regulate many other
physiological functions. The overexpression of COX-2 leads
to the over production of PGs– like PGE2– and in turn leads
to a broad array of diseases like inflammation, Alzheimer’s,
rheumatoid arthritis and many cancers such as prostate,
colon and breast cancer. Of all the prostaglandins, PGE2 is
most implicated in cancer progression and the development
of more advanced phenotypes such as metastasis.
The COX-2 protein is located in the membrane of the
endoplasmic reticulum and the nuclear envelope. The
enzyme has five potential N-linked glycosylation sites –
Asn53, Asn130, and Asn396 are always glycosylated, Asn592 is
never glycosylated, and Asn580 is glycosylated 50% of the
time. This latter variable glycosylation site produces two
































































































Effect of glycosylation of COX-2 at Asn580 on the migratory (A) and invasive (B)
abilities of MCF-7 cells. Control = MCF-7 cells transfected with empty plasmid; 72/74
kDa = MCF-7 cells expressing the 72 kDa and 74 kDa COX-2 glycoforms; 70/72 kDa =
MCF-7 cells expressing the 70 and 72 kDa COX-2 glycoforms. Results are averages ±
SEM; n = 3 - 4 independent experiments.
Effect of glycosylation of COX-2 at Asn580 on the migratory (A) and invasive (B)
abilities of COS-1 cells. Control = COS-1 cells transfected with empty plasmid; 72/74
kDa = COS-1 cells expressing the 72 kDa and 74 kDa COX-2 glycoforms; 70/72 kDa =
COS-1 cells expressing the 70 and 72 kDa COX-2 glycoforms. Results are average ±
SEM; n = 3 - 4 independent experiments.
• Lack of glycosylation of COX-2 at Asn580 enhances the
migratory and invasive potential of COS-1 cells.
• However, the addition of glycosylation at Asn580 enhances the
migratory and invasive ability of MCF-7 cells.
• The prostaglandin E2 receptor, EP2 is up-regulated in MCF-7
cells overexpressing COX-2, regardless of its glycosylation
state. Result may partially explain the molecular mechanism
behind COX-2’s role in metastasis.
Figure 2
RT-PCR detection of EP-2 receptors in MCF7 cells. C = MCF-7 cells transfected
with empty plasmid; Wt = MCF-7 cells transfected with the wild-type COX-2 gene; M =
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